{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:24:49Z","timestamp":1794338689186,"version":"4.9.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ljubljana University Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110401","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T23:20:31Z","timestamp":1592608831000},"page":"110401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-5428","authenticated-orcid":false,"given":"David","family":"Lukanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maru\u0161a","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Kobal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-8716","authenticated-orcid":false,"given":"Katarina","family":"\u010cerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2020.110401_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2020.110401_bib0010","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ejca.2015.07.022","article-title":"Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: results of the EUROCARE-5 study","volume":"51","author":"Sant","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2020.110401_bib0015","series-title":"Ginekologija in Perinatologija","first-page":"320","article-title":"Operativno zdravljenje v ginekolo\u0161ki onkologiji","author":"Kobal","year":"2016"},{"key":"10.1016\/j.biopha.2020.110401_bib0020","series-title":"Zdru\u017eenje za radioterapijo in onkologijo SZD, Zdru\u017eenje za ginekolo\u0161ko onkologijo, kolposkopijo in cervikalno patologijo SZD","article-title":"Smernice za obravnavo bolnic z rakom jaj\u010dnikov, jajcevodov in s primarnim peritonealnim seroznim rakom","author":"Zobec Logar","year":"2016"},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/raon-2017-0008","article-title":"Cancer burden in Slovenia with the time trends analysis","volume":"51","author":"Zadnik","year":"2017","journal-title":"Radiol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.biopha.2020.110401_bib0035","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1200\/JCO.19.01009","article-title":"Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer","volume":"37","author":"Tewari","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5\u2014a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0045","first-page":"1091","article-title":"Molecular biology of the cell","volume":"20","author":"Alberts","year":"2002","journal-title":"Garland Science"},{"issue":"5","key":"10.1016\/j.biopha.2020.110401_bib0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0055","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3390\/ijms18102171","article-title":"Emerging therapeutics to overcome chemoresistance in epithelial ovarian cancer: a mini-review","volume":"18","author":"Cornelison","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110401_bib0060","series-title":"Ovarian Cancer\u2014A Clinical and Translational Update","article-title":"Molecular mechanisms of platinum resistance in ovarian cancer","author":"Tapia","year":"2013"},{"issue":"5","key":"10.1016\/j.biopha.2020.110401_bib0065","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/ijms19051486","article-title":"Modulating chemosensitivity of tumors to platinum-based antitumor drugs by transcriptional regulation of copper homeostasis","volume":"19","author":"Lai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110401_bib0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17425255.2017.1332179","article-title":"The role of membrane transporters in ovarian cancer chemoresistance and prognosis","volume":"13","author":"Cerovska","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2020.110401_bib0075","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.2147\/CMAR.S200524","article-title":"Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer","volume":"11","author":"Jiang","year":"2019","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0305-7372(85)90015-5","article-title":"Preclinical studies identifying carboplatin as a viable cisplatin alternative","volume":"12","author":"Harrap","year":"1985","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2020.110401_bib0085","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1684\/bdc.2011.1464","article-title":"Pharmacology of platinum compounds: differences between the three molecules and factors of interpatient variability","volume":"98","author":"Chatelut","year":"2011","journal-title":"Bull. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/annonc\/mdw083","article-title":"Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer","volume":"27","author":"Krzystyniak","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0095","first-page":"e104","article-title":"Mechanisms of chemoresistance in human ovarian cancer at a glance","volume":"2","author":"Liu","year":"2012","journal-title":"Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0105","first-page":"17","article-title":"Epitelijski rak jaj\u010dnikov, rak jajcevodov, primarni peritonealni serozni karcinom (PPSC): priporo\u010dila za sistemsko zdravljenje","volume":"19","author":"Skof","year":"2015","journal-title":"Onkologija: strokovno-znanstveni \u010dasopis za zdravnike"},{"issue":"5","key":"10.1016\/j.biopha.2020.110401_bib0110","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"3-4","key":"10.1016\/j.biopha.2020.110401_bib0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110401_bib0120","first-page":"1312","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance","volume":"60","author":"Komatsu","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0125","first-page":"6559","article-title":"Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper","volume":"62","author":"Katano","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/mol.64.2.466","article-title":"The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells","volume":"64","author":"Katano","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"14","key":"10.1016\/j.biopha.2020.110401_bib0135","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","article-title":"Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells","volume":"10","author":"Samimi","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110401_bib0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0753-3322(03)00012-X","article-title":"Trace elements in human physiology and pathology","volume":"57","author":"Tapiero","year":"2003","journal-title":"Copper. Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110401_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-394390-3.00006-9","article-title":"Regulation of copper transporters in human cells","volume":"69","author":"Hasan","year":"2012","journal-title":"Curr. Top. Membr."},{"issue":"2","key":"10.1016\/j.biopha.2020.110401_bib0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","article-title":"Human copper homeostasis: a network of interconnected pathways","volume":"14","author":"Lutsenko","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-018-0277-3","article-title":"Copper signalling: causes and consequences","volume":"16","author":"Kardos","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2020.110401_bib0160","first-page":"181","article-title":"Role of copper and selenium in reproductive biology: a brief update","volume":"4","author":"Pal","year":"2015","journal-title":"Biochem. Pharmacol. (Los Angel)"},{"key":"10.1016\/j.biopha.2020.110401_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.talanta.2013.05.016","article-title":"A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection","volume":"116","author":"Martin\u010di\u010d","year":"2013","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/nyas.12427","article-title":"ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A","volume":"1314","author":"Yi","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2020.110401_bib0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.2007.052746","article-title":"Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes","volume":"44","author":"de Bie","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.biopha.2020.110401_bib0180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/14728222.2015.1043269","article-title":"Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy","volume":"19","author":"Chen","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.biopha.2020.110401_bib0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C6MT00202A","article-title":"Defining the human copper proteome and analysis of its expression variation in cancers","volume":"9","author":"Blockhuys","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2020.110401_bib0195","first-page":"2811","article-title":"Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer","volume":"34","author":"Duechler","year":"2014","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110401_bib0200","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1535-7163.MCT-11-0864","article-title":"Overcoming platinum resistance through the use of a copper-lowering agent","volume":"11","author":"Fu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2020.110401_bib0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fonc.2019.00437","article-title":"A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial ovarian, tubal, and peritoneal cancer within 12 months after platinum-based chemotherapy","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.abb.2007.04.021","article-title":"Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis","volume":"463","author":"La Fontaine","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2020.110401_bib0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Issue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110401_bib0220","first-page":"5853","article-title":"Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients","volume":"9","author":"Samimi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0225","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-03-0454","article-title":"Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy","volume":"10","author":"Nakayama","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iub.1722","article-title":"Copper efflux transporters ATP7A and ATP7B: novel biomarkers for platinum drug resistance and targets for therapy","volume":"70","author":"Li","year":"2018","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.biopha.2020.110401_bib0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1515\/hsz-2011-0249","article-title":"Structural models of the human copper P-type ATPases ATP7A and ATP7B","volume":"393","author":"Gourdon","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110401_bib0240","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1073\/pnas.1012899108","article-title":"Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro","volume":"108","author":"Palm","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110401_bib0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/anie.201307718","article-title":"Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B","volume":"53","author":"Tadini-Buoninsegni","year":"2014","journal-title":"Angew Chem"},{"key":"10.1016\/j.biopha.2020.110401_bib0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jinorgbio.2008.11.012","article-title":"Effects of the loss of Atox1 on the cellular pharmacology of cisplatin","volume":"103","author":"Safaei","year":"2009","journal-title":"J. Inorg. Biochem."},{"issue":"13","key":"10.1016\/j.biopha.2020.110401_bib0255","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-03-0689","article-title":"Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells","volume":"10","author":"Katano","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0260","first-page":"279","article-title":"Role of transporter genes in cisplatin resistance","volume":"22","author":"Konkimalla","year":"2008","journal-title":"Vivo"},{"key":"10.1016\/j.biopha.2020.110401_bib0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2407-8-175","article-title":"Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells","volume":"8","author":"Kalayda","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2020.110401_bib0270","doi-asserted-by":"crossref","first-page":"E608","DOI":"10.3390\/cancers12030608","article-title":"Synthetic lethality screening identifies FDA-Approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin","volume":"12","author":"Mariniello","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2020.110401_bib0275","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-08-2306","article-title":"Therapeutic targeting of ATP7B in ovarian carcinoma","volume":"15","author":"Mangala","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0280","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","article-title":"Function and regulation of human copper-transporting ATPases","volume":"87","author":"Lutsenko","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2020.110401_bib0285","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.756.11.2","article-title":"Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells","volume":"1","author":"Safaei","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2020.110401_bib0290","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2020.110401_bib0295","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1124\/mol.104.001198","article-title":"The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells","volume":"66","author":"Holzer","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110401_bib0300","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/genes10070510","article-title":"Insight into the role of extracellular vesicles in lysosomal storage disorders","volume":"10","author":"Tancini","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2020.110401_bib0305","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2343876","article-title":"Targeting V-ATPase isoform restores cisplatin activity in resistant ovarian cancer: inhibition of autophagy, endosome function, and ERK\/MEK pathway","volume":"2019","author":"Kulshrestha","year":"2019","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110401_bib0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/mol.107.040980","article-title":"Transport of cisplatin by the copper efflux transporter ATP7B","volume":"73","author":"Safaei","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110401_bib0315","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/cells8091080","article-title":"Activity and trafficking of copper-transporting ATPases in tumor development and defense against platinum-based drugs","volume":"8","author":"Petruzzelli","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41598-017-00618-6","article-title":"Characterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease","volume":"7","author":"Skjorringe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110401_bib0325","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.7150\/jca.19029","article-title":"Role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance","volume":"8","author":"Zhu","year":"2017","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2020.110401_bib0330","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dgd.12043","article-title":"Embryonic fibroblasts represent a connecting link between mesenchymal and embryonic stem cells","volume":"55","author":"Yusuf","year":"2013","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.biopha.2020.110401_bib0335","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ijc.10608","article-title":"Copper-transporting P-type adenosine triphophatase (ATP7B) as a cisplatin-based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP, LRP and BCRP","volume":"101","author":"Nakayama","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2020.110401_bib0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3892\/ol_00000049","article-title":"ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer","volume":"1","author":"Inoue","year":"2010","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2020.110401_bib0345","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1349-7006.2002.tb01202.x","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma","volume":"93","author":"Mori","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110401_bib0350","first-page":"337","article-title":"Expression of copper-transporting P-type adenosine triphosphatase in human esophageal carcinoma","volume":"11","author":"Higashimoto","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110401_bib0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1368-8375(02)00038-6","article-title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin","volume":"39","author":"Miyashita","year":"2003","journal-title":"Oral Oncol."},{"key":"10.1016\/j.biopha.2020.110401_bib0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(02)00462-7","article-title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma","volume":"189","author":"Ohbu","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2020.110401_bib0365","doi-asserted-by":"crossref","first-page":"774","DOI":"10.5414\/CP202907","article-title":"Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer","volume":"55","author":"Li","year":"2017","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2020.110401_bib0370","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/tpj.2015.52","article-title":"Carboplatin\/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial","volume":"16","author":"He","year":"2016","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.biopha.2020.110401_bib0375","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","article-title":"The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Meinhold-Heerlein","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"issue":"39","key":"10.1016\/j.biopha.2020.110401_bib0380","doi-asserted-by":"crossref","first-page":"36289","DOI":"10.1074\/jbc.M102055200","article-title":"Copper specificall regulates intracellular phosphorylation of the Wilson\u2019s disease protein, a human copper- transporting ATPase","volume":"276","author":"Vanderwerf","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2020.110401_bib0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13046-019-1292-y","article-title":"Role of protein kinase CK2 in antitumor drug resistance","volume":"38","author":"Borgo","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110401_bib0390","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/1535-7163.MCT-11-0613","article-title":"CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy","volume":"11","author":"Siddiqui-Jain","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2020.110401_bib0395","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2020.110401_bib0400","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3332\/ecancer.2018.837","article-title":"Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis","volume":"12","author":"Cadena","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.biopha.2020.110401_bib0405","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.redox.2018.03.007","article-title":"Copper accumulation in senescent cells: interplay between copper transporters and impaired autophagy","volume":"16","author":"Masaldana","year":"2018","journal-title":"Redox Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:02:56Z","timestamp":1760097776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220305941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"alternative-id":["S0753332220305941"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110401","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110401"}}